BPC-157
A gut-derived peptide with remarkable tissue-healing effects in animal models โ and a striking lack of published human trial data
Peptides claimed to accelerate soft-tissue healing, reduce inflammation, and support gut repair. Evidence quality varies from promising animal data (BPC-157, TB-500) to well-characterized antimicrobial/wound pathways (LL-37). Most are research-use-only.
A gut-derived peptide with remarkable tissue-healing effects in animal models โ and a striking lack of published human trial data
A synthetic fragment loosely based on Thymosin Beta-4 โ a real, extensively studied actin-binding peptide โ but the "TB-500" research chemical sold online is not what any human trial has ever actually tested
A naturally occurring copper tripeptide with solid cell-culture and animal evidence for wound healing and skin regeneration โ and small but published human cosmetic trials
Endogenous 37-residue cationic peptide with broad antimicrobial and immunomodulatory activity. Investigational for infection, wound healing and chronic ulcers.
C-terminal tripeptide of ฮฑ-MSH. Anti-inflammatory in gut and skin models; no regulatory approval as a medicine.
Mixture of low-molecular-weight peptides and amino acids derived from purified porcine brain protein. Approved in many countries for stroke and dementia; evidence is mixed.